NYSE$EHAB
Enhabit Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Enhabit reported a slight decline in net service revenue and a significant decrease in net income and adjusted EBITDA for the fourth quarter of 2022.
Enhabit, Inc. reported net service revenue of $275.1 million for the fourth quarter of 2022, a 0.4% decline from Q4 2021. Net income decreased by 72.5% to $8.2 million, and Adjusted EBITDA was down 17.8% to $40.3 million.
- Net service revenue for Q4 2022 was $275.1 million, a slight decrease of 0.4% compared to Q4 2021.
- Net income for Q4 2022 significantly declined by 72.5% to $8.2 million.
- Adjusted EBITDA for Q4 2022 was $40.3 million, representing a 17.8% decrease from the prior year.
- Home health Medicare Advantage experienced strong growth with nine new negotiated agreements added during the fourth quarter.
Headline financials
Revenue & EPS history
Enhabit · Revenue · Quarterly
$275M
Revenue by segment
Enhabit · $263M total across 2 segments · Q4 2022
- Home Health$216M—82.0%
- Hospice$47.4M—18.0%
Forward guidance
Enhabit provided full-year 2023 guidance with net service revenue projected between $1,110 million and $1,140 million, Adjusted EBITDA between $125 million and $140 million, and Adjusted EPS between $0.50 and $0.89.
Tailwinds
- The company is confident in the long-term prospects for Enhabit despite facing numerous headwinds in 2023.
- Expansion of human resource and talent acquisitions teams is making notable progress.
- Establishment of a payor innovation team is making notable progress.
- Strategic changes to management and the staffing model in hospice are making notable progress.
- Operational and sales teams are being aligned into a regional structure to drive clinical and operational success at a local level.
Headwinds
- The company faces numerous headwinds in 2023.
- The guidance for comparable GAAP measures for Adjusted EBITDA and Adjusted EPS is not provided due to inherent difficulty in predicting future impacts of certain items.
- Future impacts of items like gains or losses related to hedging instruments are outside the company's control.
- Loss on early extinguishment of debt is an unpredictable factor.
- Adjustments to income tax provision (e.g., valuation allowance adjustments and settlements of income tax claims) and items related to corporate and facility restructurings are difficult to forecast.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 14 quarterly earnings reports · overlaid with Q4 2022
+1.9%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+8.6%
Avg return
30 days after
40%
6 / 15 earnings
Positive
+18.2%
Q1 2025
Best reaction
-6.1%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +0.1% | — | |
| Q4 2025 | +0.0% | +0.0% | +2.9% | |
| Q3 2025 | -6.1% | -2.7% | +13.6% | |
| Q2 2025 | +15.2% | +11.4% | +15.1% | |
| Q1 2025 | +18.2% | +27.7% | +31.7% | |
| Q4 2024 | +1.6% | +2.3% | +13.3% | |
| Q3 2024 | -0.4% | -5.7% | -12.0% | |
| Q2 2024 | +0.0% | -3.1% | +14.8% | |
| Q1 2024 | +0.0% | -5.4% | -13.4% | |
| Q4 2022 | +0.0% | -5.7% | -0.4% | |
| Q3 2023 | +6.1% | +6.7% | +19.3% | |
| Q2 2023 | -2.6% | -2.9% | +5.6% | |
| Q1 2023 | -4.5% | -6.0% | -2.0% | |
| Q3 2022 | -0.1% | +1.9% | +11.3% | |
| Q2 2022 | +1.7% | +5.1% | +20.6% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro